Drug class: Mounjaro is a dual-action glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Moreover, real-world evidence derived from the US Collaborative Network of TriNetX, which analyzed data from individuals with T2DM aged 18 years who initiated tirzepatide or a GLP-1 RA between June 1, 2022, and June 30, 2023, suggests that tirzepatide reduces the risk of all-cause mortality by 42%, MACE by 20%, and major adverse kidney events by 46% [84]
degree from the University of Miami School of Medicine where he was awarded the Leonard G
If youre considering GLP-1 therapy, this is also a good time to know that you dont need to be perfectly structured for it to work for you
Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy
The disease may require an extended stay in the hospital